Furthermore, several studies have revealed that a reduced level of hepcidin may have a beneficial impact on preventing ferroptosis in various disease models, such as subarachnoid hemorrhage [7], chronic atrophic gastritis [52], and acute liver injury [53,54,55]. This evidence concerns the gene HAMP and subarachnoid hemorrhage.